<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40915405</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1913</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Sep</Month><Day>05</Day></PubDate></JournalIssue><Title>The American journal of cardiology</Title><ISOAbbreviation>Am J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Principles of Coronary Sinus Narrowing to Relieve Myocardial Ischemia and Improve Angina.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0002-9149(25)00539-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjcard.2025.08.066</ELocationID><Abstract><AbstractText>Effective therapy for patients suffering from refractory angina remains a major unmet need. Chronic angina, which is refractory to medical and interventional therapies, affects patients who are not suitable for revascularization, patients following successful revascularization, and patients with coronary microvascular dysfunction. Coronary sinus (CS) narrowing has been studied as a potential therapy for patients with angina. Pre-clinical and clinical data, including 2 randomized sham-controlled clinical trials and 2 large prospective multi-center registries, have confirmed the safety and effectiveness of CS narrowing in patients with refractory angina due to obstructive coronary artery disease (CAD). Preliminary pathophysiologic studies suggest that CS narrowing may also improve coronary microvascular function and alleviate microvascular angina. Here, we review the historical perspective, mechanism of action, and clinical applications of CS narrowing. In Conclusion: With the accumulation of new data, the time is ripe to revisit the therapeutic benefits seen in historical CS interventions and demonstrated in recent clinical research to reduce angina and ischemia and improve quality of life of patients with disabling refractory angina.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prasad</LastName><ForeName>Megha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CUIMC/Herbert Irving Pavilion, NY, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konigstein</LastName><ForeName>Maayan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tel Aviv Medical Center, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de-Silva</LastName><ForeName>Ranil</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NHLI Imperial College London Royal Brompton and Harefield Hospitals.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lerman</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banai</LastName><ForeName>Shmuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tel Aviv Medical Center, Tel Aviv, Israel. Electronic address: banaishm@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Cardiol</MedlineTA><NlmUniqueID>0207277</NlmUniqueID><ISSNLinking>0002-9149</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ANOCA</Keyword><Keyword MajorTopicYN="N">coronary sinus reducer</Keyword><Keyword MajorTopicYN="N">non obstructive coronary artery disease</Keyword><Keyword MajorTopicYN="N">obstructive coronary artery disease</Keyword><Keyword MajorTopicYN="N">refractory angina</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Shmuel Banai reports were provided by Tel Aviv Sourasky Medical Center. Shmuel Banai reports a relationship with Shockwave Medical Inc that includes: consulting or advisory. None If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>0</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>0</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>7</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40915405</ArticleId><ArticleId IdType="doi">10.1016/j.amjcard.2025.08.066</ArticleId><ArticleId IdType="pii">S0002-9149(25)00539-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>